000 01445 a2200409 4500
005 20250517162248.0
264 0 _c20171221
008 201712s 0 0 eng d
022 _a0392-856X
040 _aNLM
_beng
_cNLM
100 1 _aDistler, Oliver
245 0 0 _aDesign of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™).
_h[electronic resource]
260 _bClinical and experimental rheumatology
_c
300 _a75-81 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aDouble-Blind Method
650 0 4 _aHumans
650 0 4 _aIndoles
_xtherapeutic use
650 0 4 _aLung Diseases, Interstitial
_xdrug therapy
650 0 4 _aProspective Studies
650 0 4 _aResearch Design
650 0 4 _aScleroderma, Systemic
_xcomplications
650 0 4 _aVital Capacity
700 1 _aBrown, Kevin K
700 1 _aDistler, Jörg H W
700 1 _aAssassi, Shervin
700 1 _aMaher, Toby M
700 1 _aCottin, Vincent
700 1 _aVarga, John
700 1 _aCoeck, Carl
700 1 _aGahlemann, Martina
700 1 _aSauter, Wiebke
700 1 _aSchmidt, Hendrik
700 1 _aHighland, Kristin B
773 0 _tClinical and experimental rheumatology
_gvol. 35 Suppl 106
_gno. 4
_gp. 75-81
999 _c27326311
_d27326311